Results 181 to 190 of about 76,767 (289)

Hypokalemic Periodic Paralysis in a Young Woman With Mast Cell Activation Syndrome: A Case Report of an Atypical Presentation Associated With an Ultra‐Rare CACNA1S Variant

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Hypokalemic periodic paralysis (hKPP) is a rare neuromuscular channelopathy characterized by transient episodes of muscle weakness or paralysis associated with low serum potassium levels. It has been most commonly linked to autosomal dominant mutations in ion channel genes, specifically CACNA1S and SCN4A, which impair skeletal muscle ...
Ali Moradi   +8 more
wiley   +1 more source

Clinical Pattern of Graves' Disease and Management Preferences Among Pediatric Endocrinologists in Saudi Arabia, A Decade of Experience. [PDF]

open access: yesClin Med Insights Endocrinol Diabetes
Al Shaikh A   +8 more
europepmc   +1 more source

First‐line envafolimab plus recombinant human‐endostatin in advanced non–small cell lung cancer with PD‐L1 tumor proportion score ≥1% (Endouble): A multicenter, prospective, single‐arm, phase 2 trial

open access: yesCancer, Volume 132, Issue 11, 1 June 2026.
Envafolimab combined with recombinant human endostatin demonstrates favorable efficacy and tolerable toxicity in non–small cell lung cancer patients. MMP1 and TNFRSF6B may be predictive biomarkers for treatment response. Abstract Background This trial evaluates the efficacy and safety of combining envafolimab and recombinant human endostatin (Rh ...
Changhong Dong   +22 more
wiley   +1 more source

Recurrent Goiter, Hyperthyroidism, Galactorrhea and Amenorrhea due to a Thyrotropin ans Prolactin-Producing Pituitary Tumor [PDF]

open access: yes, 1976
Erhardt, F.   +5 more
core   +1 more source

Efficacy of Ritlecitinib for Vitiligo Treatment Stratified by Baseline Demographic and Clinical Characteristics: Post Hoc Analysis of a Phase 2b Study

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 571-576, June 2026.
This post hoc analysis examined the efficacy of ritlecitinib in subgroups of patients with vitiligo, defined by demographic and clinical characteristics. Patients completed the dose‐ranging and extension periods of the phase 2b study (NCT03715829) of ritlecitinib.
A. G. Pandya   +8 more
wiley   +1 more source

Thyroid lobe agenesis: a rare clinical finding. [PDF]

open access: yesJCEM Case Rep
Diaz-Cuadrado I   +3 more
europepmc   +1 more source

Graves' Disease: Prospective Up to 10‐Year Outcome for 100 Consecutive Individuals at a Single Centre

open access: yes
Clinical Endocrinology, Volume 105, Issue 1, Page 122-125, July 2026.
Muhammad Muneeb Ibad   +12 more
wiley   +1 more source

Atrial fibrillation and associated cardiovascular disorders in adults with hyperthyroidism: a retrospective cohort study from two teaching hospitals. [PDF]

open access: yesThyroid Res
Mengistie BT   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy